
DMT
{The Spirit Molecule, Jungle Spice, Dimitri, the Businessman’s trip, Fantasia}
Put your brand in front of thousands monthly and support the growth of harm reduction.
Harm Reduction
Drugs are dangerous. Really, we should just avoid them, that much is true. But if you are going to take DMT then there are certain precautions that can reduce that risk. We’ve separated these into tips for preparing yourself beforehand, taking care of yourself and others during, and ways to mitigate the after-effects. Head over to our ME section if you would like to know more about harm reduction.
Before
- Trip sitter. It is imperative to have a trip sitter (someone with you who is completely sober). Mostly to take the pipe away after smoking to avoid burning yourself.
- Set and setting. Psychedelics amplify your state of mind so it’s important to be in a nice place with people you trust and are comfortable with (setting), but also in a good state of mind (set). This will help avoid a scary and overwhelming experience (bad trip)
- Comfortable. Make the area where you are about to trip comfortable (setting), gather pillows and blankets as you will really be able to during the experience.
- Pen and paper. The DMT experience is quite similar to a dream in the sense that it will start to fade rapidly. Jot down your experience and your thoughts quickly. This will also help when integrating your experience.
- Hydration. Drink some water before and have a bottle of water to hand.
References
Websites
https://psychonautwiki.org/wiki/DMT
https://www.medicalnewstoday.com/articles/306889.php
https://erowid.org/chemicals/dmt/dmt.shtml
https://erowid.org/library/books\_online/tihkal/tihkal06.shtml
https://erowid.org/chemicals/dmt/dmt\_culture1.shtml
https://www.legislation.gov.uk/ukpga/1971/38/contents
Papers
Barker, S. (2018). N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function. Frontiers in Neuroscience, 12.
Nichols, D. (2016). Psychedelics. Pharmacological Reviews, 68(2), pp.264-355.
dos Santos, R., Bouso, J. and Hallak, J. (2017). Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. Therapeutic Advances in Psychopharmacology, 7(4), pp.141-157.
Strassman, R. J. (1984). Adverse reactions to psychedelic drugs. A review of the literature. The Journal of Nervous and Mental Disease, 172(10), 577-595.
Szabo, A. and Frecska, E. (2016). Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?. Neural Regeneration Research, 11(3), p.396.
Put your brand in front of thousands monthly and support the growth of harm reduction.